logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

New Treatment Strategies For Dengue And Other Flaviviral Diseases Novartis Foundation Symposium 277 Novartis Foundationeds

  • SKU: BELL-4309166
New Treatment Strategies For Dengue And Other Flaviviral Diseases Novartis Foundation Symposium 277 Novartis Foundationeds
$ 31.00 $ 45.00 (-31%)

4.3

88 reviews

New Treatment Strategies For Dengue And Other Flaviviral Diseases Novartis Foundation Symposium 277 Novartis Foundationeds instant download after payment.

Publisher: Wiley
File Extension: PDF
File size: 11.45 MB
Pages: 275
Author: Novartis Foundation(eds.)
ISBN: 9780470016435, 9780470058008, 0470016434, 0470058005
Language: English
Year: 2006

Product desciption

New Treatment Strategies For Dengue And Other Flaviviral Diseases Novartis Foundation Symposium 277 Novartis Foundationeds by Novartis Foundation(eds.) 9780470016435, 9780470058008, 0470016434, 0470058005 instant download after payment.

Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease.

This book features contributions from the world’s leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease.

With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology.

Praise from the reviews:

"The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases." MICROBIOLOGY TODAYContent:

Related Products